Perclose ProGlide devices simplified the removal of the femoral venous cannulas for the transcatheter closure of atrial septal defect: A single-center retrospective study

OBJECTIVE: This study aimed to assess the effectiveness, feasibility, and security of the Perclose ProGlide device that was used to remove the femoral venous cannulas for the transcatheter closure of atrial septal defect (ASD). METHODS: A total of 145 cases were analyzed retrospectively, who performed transcatheter closure of ASD in our center from March 2019 to March 2021. Based on whether the Perclose ProGlide device was placed or not in the femoral vein, 48 patients were assigned to the Perclose group and 97 ones to the non-Perclose group. The data of general characteristics, femoral venous cannulas, and related puncture complications were compared between the two groups. RESULTS: The data of general characteristics or femoral venous cannulas were not significantly different between the two groups, but the procedure duration of removing venous cannulas was shorter in the Perclose group (0.5 min [0.35, 0.70] vs. 5 min [3.6, 7.4], P < 0.001). The puncture procedure-related blood lose was not significantly different between the two groups (Hemoglobin reduction value: 0.10 [−0.47, 0.30] g/dL vs. 0.10 [−0.50, 0.30] g/dL, P = 0.905). In addition, other complications caused by the removal of venous cannulas, length of stay in the ward, puncture infection, reintervention, and so on were not significantly different between the groups. CONCLUSIONS: The Perclose ProGlide device could simplify the removal of femoral venous cannulas for ASD transcatheter closure by decreasing procedure duration and time in bed. The efficiency, feasibility, and safety of Perclose ProGlide devices, which were used to remove venous cannulas, are good enough for their clinical application.